Amgen targets $34.3B-$35.7B in 2025 revenues with strong growth in key therapeutic areas
Q4 2024 . Management View. Amgen highlighted its robust performance in 2024, achieving 14 products annualizing over $1 billion in ...
Morgan Stanley cuts Regeneron stock price target to $1,150
Pharmaceuticals stock, reducing the price target from $1,185.00 to $1,150.00. Despite the decrease, the firm maintained its Overweight rating on the NASDAQ-listed company. According to InvestingPro ...
STAT9h
Study of Amgen’s early obesity candidate paused by FDA
The company said the agency's hold was "not related to the drug,” dubbed AMG 513, and that discussions were underway to ...
Investor's Business Daily on MSN11h
Amgen Beat Fourth-Quarter Expectations. So, Why Did Shares Tumble?
Amgen stock dipped late Tuesday on lighter-than-expected profit guidance for 2025, despite a strong fourth-quarter report.
Amgen profit beats estimates, next MariTide studies start by mid-year
Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...
STAT15h
No, Bernie Sanders and Elizabeth Warren aren’t top recipients of pharmaceutical industry donations
A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...
FiercePharma16h
World Cancer Day 2025: Merck, Pfizer, GSK among pharmas raising awareness of prevention, detection, treatment options
In 2000, the Union for International Cancer Control (UICC) named Feb. | In 2000, the Union for International Cancer Control named Feb. 4 World Cancer Day, with a goal of raising awareness of cancer ...
Piper Sandler Sticks to Their Buy Rating for Amneal Pharmaceuticals (AMRX)
In a report released today, David Amsellem from Piper Sandler maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report), with ...